(Q46081458)

19 December 2017

title

Upregulation of LRIG1 suppresses malignant glioma cell growth by attenuating EGFR activity (English)

1 reference

19 December 2017

1 reference

Fei Ye

1

1 reference

19 December 2017

Qinglei Gao

2

1 reference

19 December 2017

Tongjiang Xu

3

1 reference

19 December 2017

Liang Zeng

4

1 reference

19 December 2017

Yibo Ou

5

1 reference

19 December 2017

Feng Mao

6

1 reference

19 December 2017

Heping Wang

7

1 reference

19 December 2017

Yue He

8

1 reference

19 December 2017

Baofeng Wang

9

1 reference

19 December 2017

Zhengming Yang

10

1 reference

19 December 2017

Dongsheng Guo

11

1 reference

19 December 2017

Ting Lei

12

1 reference

19 December 2017

publication date

20 March 2009

1 reference

19 December 2017

Journal of Neuro-Oncology

published in

1 reference

19 December 2017

volume

94

1 reference

19 December 2017

issue

2

1 reference

19 December 2017

page(s)

183-194

1 reference

19 December 2017

https://scigraph.springernature.com/pub.10.1007/s11060-009-9836-1

exact match

0 references

cites work

Loss of PTEN/MMAC1/TEP in EGF receptor-expressing tumor cells counteracts the antitumor action of EGFR tyrosine kinase inhibitors

1 reference

12 December 2020

Cell signaling by receptor tyrosine kinases

1 reference

12 December 2020

Signal integration during development: mechanisms of EGFR and Notch pathway function and cross-talk

1 reference

12 December 2020

LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy

1 reference

12 December 2020

Crosstalk between androgen receptor and epidermal growth factor receptor-signalling pathways: a molecular switch for epithelial cell differentiation.

1 reference

12 December 2020

Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer

1 reference

12 December 2020

Mechanism of inhibition of the Drosophila and mammalian EGF receptors by the transmembrane protein Kekkon 1.

1 reference

12 December 2020

Endocytosis of Receptor Tyrosine Kinases Is Driven by Monoubiquitylation, Not Polyubiquitylation

1 reference

12 December 2020

Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia

1 reference

12 December 2020

Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cells.

1 reference

12 December 2020

The transmembrane molecule kekkon 1 acts in a feedback loop to negatively regulate the activity of the Drosophila EGF receptor during oogenesis.

1 reference

12 December 2020

Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors

1 reference

12 December 2020

Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathwa

1 reference

12 December 2020

Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.

1 reference

12 December 2020

LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis

1 reference

12 December 2020

Antisense oligonucleotides to the epidermal growth factor receptor

1 reference

12 December 2020

The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases

1 reference

12 December 2020

LRIG inhibitors of growth factor signalling - double-edged swords in human cancer?

1 reference

12 December 2020

Untangling the ErbB signalling network

1 reference

12 December 2020

Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas

1 reference

12 December 2020

Oncolytic adenovirus-mediated transfer of the antisense chk2 selectively inhibits tumor growth in vitro and in vivo

1 reference

12 December 2020

The LRIG gene family has three vertebrate paralogs widely expressed in human and mouse tissues and a homolog in Ascidiacea

1 reference

12 December 2020

Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo.

1 reference

12 December 2020

Targeting HER proteins in cancer therapy and the role of the non-target HER3.

1 reference

12 December 2020

Resistance to gefitinib in PTEN-null HER-overexpressing tumor cells can be overcome through restoration of PTEN function or pharmacologic modulation of constitutive phosphatidylinositol 3'-kinase/Akt pathway signaling.

1 reference

12 December 2020

Insulin-like growth factor receptor I mediates resistance to anti-epidermal growth factor receptor therapy in primary human glioblastoma cells through continued activation of phosphoinositide 3-kinase signaling

1 reference

12 December 2020

Cbl-b-dependent coordinated degradation of the epidermal growth factor receptor signaling complex

1 reference

12 December 2020

LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation

1 reference

12 December 2020

Response of glioblastomas to EGFR kinase inhibitors

1 reference

12 December 2020

c-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptor

1 reference

12 December 2020

Protein tyrosine kinases and cancer

1 reference

12 December 2020

Selective targeting of checkpoint kinase 1 in tumor cells with a novel potent oncolytic adenovirus

1 reference

12 December 2020

Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab

1 reference

12 December 2020

EGFR inhibitor-mediated apoptosis in solid tumors.

1 reference

12 December 2020

Novel oncolytic adenovirus selectively targets tumor-associated polo-like kinase 1 and tumor cell viability

1 reference

12 December 2020

10.1007/S11060-009-9836-1

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

19300910

1 reference

19 December 2017